June 16, 2023
June 15, 2023
CCH registration is NOW OPEN
Registration for APC’s annual DC fly-in, Compounders on Capitol Hill, opened today. Act now to take advantage of our discounted early-bird registration—including extra-special pricing for our PFM members.
June 9, 2023
Topi-CLICK bumps up!
APC corporate supporter Topi-CLICK has recently increased its support for APC, moving from a $10,000 investment to an annual $25,000 investment.
June 9, 2023
A welcome clarification on veterinary bulk substances
This week in a communication with an APC member pharmacy, FDA’s Center for Veterinary Medicine made some clarifications.
June 9, 2023
Couple of quick state updates
APC and NCPA have sent a joint letter to the Oregon Board of Pharmacy expressing concern about the agency’s recent fiscal impact request regarding proposed rules on pharmacist licensure and counseling requirements.
June 9, 2023
Congressional letter deadline is today
Today is the last day for members of Congress to add their names to a joint letter to FDA in support of maintaining access to compounded hormones. The letter is led by Rep. Jennifer Wexton (D-VA).
June 9, 2023
CCH early bird registration opens June 15
Attendee registration opens June 15 for APC’s annual DC fly-in, Compounders on Capitol Hill.
June 2, 2023
FDA issues public statement on compounded semaglutide
Earlier this week, FDA issued its first public statement on semaglutide compounding. The statement elaborates on what the agency said in its April letter to NABP on the subject.
June 2, 2023
Call to Action on Urgent Use: Have you responded?
Send a message to your respective members of Congress, asking them to support legislative language that will allow pharmacy compounders to help fill urgent gaps in the drug supply chain.
